Skip to main content
. 2017 Oct 26;12(10):e0184506. doi: 10.1371/journal.pone.0184506

Table 1. Baseline characteristics of study participants by non-alcoholic fatty liver disease and sex.

Characteristics Men p Women p
No NAFLD NAFLD No NAFLD NAFLD
Number 70,954 41,370 86,660 9,594
Age (years)a 36.8 (7.6) 37.9 (7.6) <0.001 36.7 (7.4) 42.8 (10.2) <0.001
BMI (kg/m2) 23.2 (2.4) 26.1 (2.7) <0.001 21.3 (2.5) 25.6 (3.3) <0.001
Obesity (%) 21.8 63.4 <0.001 8.1 52.3 <0.001
Current smoker (%) 42.1 42.2 <0.001 3.9 3.6 0.255
Alcohol intake (%)b 44.3 44.8 0.085 6.1 4.9 <0.001
Vigorous exercise (%)c 16.2 13.3 <0.001 13.8 14.8 0.007
High education level (%)d 85.2 87.4 <0.001 71.8 54.7 <0.001
Diabetes (%) 1.5 5.4 <0.001 0.7 8.2 <0.001
Hypertension (%) 12.0 21.9 <0.001 4.4 20.2 <0.001
Systolic BP (mmHg)a 114.9 (11.9) 118.7 (12.7) <0.001 105.9 (12.4) 114.8 (15.5) <0.001
Diastolic BP (mmHg)a 74.4 (8.9) 77.4 (9.5) <0.001 67.5 (8.7) 73.2 (10.3) <0.001
Glucose (mg/dl)a 93.1 (11.8) 98.7 (18.4) <0.001 90.1 (9.1) 100.1 (22.7) <0.001
Uric acid (mg/dl)a 5.9 (1.1) 6.5 (1.2) <0.001 4.1 (0.8) 4.7 (1.0) <0.001
Total cholesterol (mg/dl)a 192.3 (32.4) 208.4 (34.8) <0.001 183.9 (31.9) 204.6 (36.4) <0.001
LDL-C (mg/dl)a 114.8 (28.0) 128.7 (30.3) <0.001 103.1 (27.0) 124.8 (31.8) <0.001
HDL-C (mg/dl)a 54.1 (11.4) 48.0 (9.3) <0.001 62.5 (13.4) 53.5 (11.7) <0.001
Triglycerides (mg/dl)e 102 (76–141) 155 (113–214) <0.001 72 (56–97) 122 (88–171) <0.001
ALT (U/l)e 14 (11–20) 16 (11–22) <0.001 14 (11–19) 14 (11–18) <0.001
AST (U/l)e 18 (15–21) 18 (15–22) <0.001 18 (15–21) 18 (15–21) <0.001
GGT (U/l)e 16 (11–23) 17 (12–28) <0.001 15 (11–22) 15 (11–20) <0.001
HOMA-IRe 1.47 (1.04–1.96) 2.13 (1.55–2.82) <0.001 1.45 (0.97–1.97) 2.27 (1.60–3.10) <0.001
hsCRP (mg/l)e 0.4 (0.2–0.8) 0.7 (0.4–1.4) <0.001 0.3 (0.1–0.6) 0.9 (0.4–1.8) <0.001

Data are presented as amean (standard deviation), emedians (interquartile range), or percentage.

ALT, alanine aminotransferase; BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein-cholesterol; hsCRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance.

b ≥ 10 g of ethanol per day; c ≥ 3 times per week; d≥ College graduate